the vaccine is too over attenuated to do the same. Engel, Mary (8 September 2016). They also showed one of the doses stopped outbreaks for at least 6 months. "Live Attenuated Herpes Simplex Virus 2 Glycoprotein E Deletion Mutant as a Vaccine Candidate Defective in Neuronal Spread". A b "Mymetics HSV Vaccine Candidate". 55 Profectus BioSciences intends to use its PBS Vax therapeutic vaccine technology to engineer a vaccine for HSV-2.
Morrison and Jeffrey Cohen). Halford WP, Geltz J, Gershburg E (2013). "miRNAs and apoptosis: RNAs to die for". These are chemically engineered oligonucleotides or short segments of RNA, that can be made to mirror their target genetic material, namely herpes microRNAs. 94 95 Some members of research team at Temple University have also joined forces to create Excision BioTheraputics. Subjects: Science Essays Oppinions on Teen Sex ase.
11 Admedus HSV-2 therapeutic vaccine 12 13 Admedus, Ian Frazer DNA vaccine: codon optimized Phase II 58 Reduction in Viral Shedding, 81 Reduction in Outbreaks (post-booster). 88 However, that seemed to may have changed, since, when Vical released phase I/II results at ASM. "GlaxoSmithKline reports positive results with its shingles vaccine". 76 Genome editing edit Another area of research for HSV treatment or a potential cure is the use of genome editing. 73 There has not been any recent announcement by the company regarding their vaccine, which seems to have been taken off from the company's research product pipeline. "NIH Launches Trial of Investigational Genital Herpes Vaccine". Retrieved 26 September 2017.
Antwone fisher research papers, Vai-writing a great research paper, Human infertility research paper, How to do science research paper,